The stock of Avinger Inc (NASDAQ:AVGR) reached all time low today, Oct, 28 and still has $3.08 target or 12.00% below today’s $3.50 share price. This indicates more downside for the $72.95M company. This technical setup was reported by Barchart.com. If the $3.08 PT is reached, the company will be worth $8.75 million less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. About 205,189 shares traded hands. Avinger Inc (NASDAQ:AVGR) has declined 57.80% since March 28, 2016 and is downtrending. It has underperformed by 62.51% the S&P500.
Analysts await Avinger Inc (NASDAQ:AVGR) to report earnings on November, 3. They expect $-1.04 earnings per share, up 3.70% or $0.04 from last year’s $-1.08 per share. After $-1.06 actual earnings per share reported by Avinger Inc for the previous quarter, Wall Street now forecasts -1.89% EPS growth.
According to Zacks Investment Research, “Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company’s product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City, California.”
More notable recent Avinger Inc (NASDAQ:AVGR) news were published by: Marketwatch.com which released: “Avinger Inc. NASDAQ: AVGR” on December 15, 2011, also Prnewswire.com with their article: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation …” published on August 10, 2016, Zacks.com published: “Avinger Inc. (AVGR) Lowers Guidance, Stock Down 40%” on July 13, 2016. More interesting news about Avinger Inc (NASDAQ:AVGR) were released by: Globenewswire.com and their article: “Avinger, Inc. Announces Closing of Public Offering of Common Stock and …” published on August 16, 2016 as well as Globenewswire.com‘s news article titled: “Avinger to Present at Upcoming Investor Conferences” with publication date: October 27, 2016.
AVGR Company Profile
Avinger, Inc., incorporated on March 8, 2007, is a commercial-stage medical device company. The Firm designs, makes and sells image-guided, catheter systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Firm focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Firm makes and sells a suite of products in the United States and select European markets. The Company’s products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.